Bio-Rad Laboratories, Inc.
BIO· NYSE
Filed Aug 4, 2011 · 10-Q · 35 days after period end · 0000012208-11-000059
| Metric | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|
| Revenue | $521.70M | $467.70M | $427.18M |
| Net Income | $40.00M | $38.00M | $37.97M |
| EPS Diluted | $1.41 | $1.35 | $1.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 4, 2011 · 35 d after period end